Journals / Cukurova Medical Journal / 2019 / Cilt: 44 - Sayı: 2

Alteration of inflammatory markers and adhesion molecules in women using oral contraceptives

Oral kontraseptif kullanan kadınlarda inflamatuvar belirteçlerinin ve adezyon moleküllerinin değişimi

Pages
561–565
Publication Date
2019-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The change in the serum CRP levels might be due to the liver first pass effect.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of the study is examine the effect of oral contraceptives on the serum levels of adhesion molecules and identify if the synthetic oestrogens provide protection against atherosclerosis.Materials and Methods: The interleukin 6 (IL-6), Tumor necrosis factor alfa (TNF Alfa), Vascular cell adhesion molecule 1 (VCAM-1), Intercellular Adhesion Molecule (ICAM-1), E selectin, P selectin, C selectin, C Reactive Protein (CRP) levels and erythrocyte sedimentation rate (ESH) of patients between 18-45, without additional illness, using oral contraceptives for contraception at least for three years were compared to healthy volunteers, aged between 18-45, having regular menstruation and without any additional diseases.Results: There has been no meaningful difference between the VCAM-1, ICAM-1, E selectin, P selectin, TNF alfa, IL 6, ESH levels of the two groups.
📊
Key Findings & Data:Serum CRP levels are meaningfully higher in the group using oral contraceptives.Conclusion: Oral contraceptives change the serum levels of adhesion molecules.
💡
Conclusion & Impact:The change in the serum CRP levels might be due to the liver first pass effect.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Oral kontraseptifler · hücrelerarası yapışma molekülü-1 · Oral contraceptives

Abstract

Purpose: The aim of the study is examine the effect of oral contraceptives on the serum levels of adhesion molecules and identify if the synthetic oestrogens provide protection against atherosclerosis.Materials and Methods: The interleukin 6 (IL-6), Tumor necrosis factor alfa (TNF Alfa), Vascular cell adhesion molecule 1 (VCAM-1), Intercellular Adhesion Molecule (ICAM-1), E selectin, P selectin, C selectin, C Reactive Protein (CRP) levels and erythrocyte sedimentation rate (ESH) of patients between 18-45, without additional illness, using oral contraceptives for contraception at least for three years were compared to healthy volunteers, aged between 18-45, having regular menstruation and without any additional diseases.Results: There has been no meaningful difference between the VCAM-1, ICAM-1, E selectin, P selectin, TNF alfa, IL 6, ESH levels of the two groups. Serum CRP levels are meaningfully higher in the group using oral contraceptives.Conclusion: Oral contraceptives change the serum levels of adhesion molecules. The change in the serum CRP levels might be due to the liver first pass effect.

Özet

Amaç: Bu çalışmanın amacı, oral kontraseptiflerin adezyon moleküllerinin serum seviyelerine olan etkisini araştırarak, sentetik östrojenlerin ateroskleroza karşı koruyucu etkisi olup olmadığı saptamaktır.Gereç ve Yöntem: Ek hastalığı bulunmayan, kontrasepsiyon amaçlı en az 3 aydır oral kontraseptif kullanan, 18-45 yaş aralığında olan hastaların serum interlökin 6 (İL-6), tümör nekrozis faktör alfa (TNF alfa), damarsal hücre yapışma molekülü 1 (VCAM-1), hücreler arası adezyon molekülü (ICAM-1), E selektin, P selektin, c reaktif protein (CRP) seviyeleri ve eritrosit sedimentasyon hızları (ESH); ek hastalığı bulunmayan, düzenli adet gören, 18-45 yaş aralığında olan sağlıklı gönüllülerle karşılaştırıldı.Bulgular: Her iki grubun VCAM-1, ICAM-1, E selektin, P selektin, TNF alfa, İL 6, ESH seviyeleri arasında anlamlı fark saptanmadı. Oral kontraseptif kullanan grupta serum CRP seviyeleri anlamlı olarak daha yüksek saptandı.Sonuç: Oral kontraseptiflerin adezyon moleküllerinin serum seviyelerini değiştirdiği gösterilemiştir. Serum crp seviyelerinin değişimleri ise karaciğer ilk geçiş etkisine bağlanmaktadır.

🔖

Cite This Article

ÖZSÜRMELİ, M., BAŞTU, E., COMBA, C., SUCU, M., ARSLAN, E., MISIRLIOĞLU, S., ÇELİK, F., ZEYBEK, Ş. Ü., BÜYÜKÖREN, A. (2019). Alteration of inflammatory markers and adhesion molecules in women using oral contraceptives. Cukurova Medical Journal, Cilt: 44 - Sayı: 2, 561–565. https://ajindex.com/articles/56449

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Nofer JR. Estrogens and atherosclerosis:insights from animal models and cell systems. J Mol Endocrinol. 2012;48:13-29
  2. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program- Adult treatment Panel 3, İnternational Diabetes Federation, and Worl Health Organization Definitions of the metabolic syndrome as predictors of incident cardiovascular diseas and diabetes. Diabetes care. 2007;30:8-13
  3. Kaseta Jr, Skafar DF, Ram JL, Jacober SJ, Sowers JR. Cardiovascular diseas in the diabetic woman. J Clin Endocrinol Metab. 1999;84:1835-38
  4. Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause. 2007;14:373- 84
  5. Libby P. The moleculer bases of acute coronary syndromes. Circulation. 1995;91:2844-50
  6. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol. 2003;91:3–6
  7. Souter I, Janzen C, Martinez Maza O, Breen EC, Stanczyk F, Chaudhuri G et al. Serum levels of soluble vascular cell adhesion molecule-1 are decreased in women receiving oral contraceptives comparede with normally menstruating women:Implications in atherosclerosis. Fertil Steril. 2005;83:1480-8
  8. Nathan L, Pervin S, Singh R, Rosenfeld M, Chaudhuri G. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis. Circulation Research. 1999;85:377–85
  9. Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL et al. Effect of postmenopausal hormones on inflammationsensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation. 1999;100:717–22
  10. Jilma B, Hildebrandt J, Kapiotis S, Wagner OF, Kitzweger E, Mullner C et al. Effects of estradiol on circulating P-selectin. J Clin Endo Metab. 1996;81:2350–5
  11. Grandi G, Napolitano A, Cagnacci A. Metabolic impact of combined hormonal contraceptives containing estradiol. Exp Opin Drug Metab Toxicol. 2016;12:779–87
  12. Souter I, Huang A, Martinez-Maza O, Breen EC, Decherney AH, Chaudhuri G et al. Serum levels of soluble vascular cell adhesion molecule-1, tumor necrosis factor-a, and interleukin-6 in in vitro fertilization cycles. Fertil Steril. 2009;91:2012–9
  13. Stocco B, Fumagalli HF, Franceschini SA, Martinez EZ, Marzocchi-Machado CM, Toloi MR. Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble